Tenders/Part 1. Vaccine against hepatitis B (HBV) for children, inj. 0.5 ml
Awarded🇵🇱PolandSupplies

Part 1. Vaccine against hepatitis B (HBV) for children, inj. 0.5 ml

Auto-translated from Polish
Original title: Część 1. Szczepionka przeciw wirusowemu zapaleniu wątroby typu B (WZW typu B) dla dzieci, inj. 0,5 ml
MINISTERSTWO ZDROWIA
Published: Sep 24, 2026
Updated: Sep 28, 2026
Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to POLYPHARM S.A. — €5,100,000

Browse open Health & Medical tenders in Poland

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Polish
1. The subject of the order is the supply of a vaccine against hepatitis B (HBV) for children, inj. 0.5 ml, on the terms specified in the SWZ. 2. Total quantity (purchase volume): 80,000 doses. 3. When selecting the most advantageous offer, the Contracting Authority reserves the right to reduce the purchase of the medicinal product, but by no more than 20% of each part of the aforementioned subject of the order, in case of exceeding the amount allocated for the execution of the order or the occurrence of objective and justified needs, in particular changes in demand among patients. 4. Pursuant to art. 256 of the Pzp Act. The Contracting Authority may annul the procurement procedure before the deadline for submitting offers, if circumstances arise that make further proceedings unjustified. 5. Pursuant to art. 257 of the Pzp Act. The Contracting Authority may annul the procurement procedure if public funds, which the Contracting Authority intended to allocate for the financing of the whole or part of the order, have not been granted to it. 6. By virtue of the Act of November 16, 2022, amending the Act on the professions of doctor and dentist and certain other acts (Journal of Laws of 2022, item 2270), the Act of August 27, 2004 on health care services financed by public funds (Journal of Laws of 2025, item 1461) was included in the financing by the National Health Fund for the acquisition of vaccines used for mandatory vaccinations within the Vaccination Program and vaccines and other immunological medicinal products constituting a reserve, used in case of an epidemic threat or epidemic. 7. Pursuant to art. 97 sec. 3 point 3d of the Act on health care services financed by public funds, the scope of the fund's activities also includes, in particular: financing the purchase of vaccines referred to in art. 18 sec. 5 of the Act of December 5, 2008 on preventing and combating infections and infectious diseases in humans, and medicinal products referred to in art. 18a sec. 2 of this Act. 8. The order must be executed in accordance with the requirements specified in the SWZ and the Draft Contract Provisions. 9. Subject evidence: Pursuant to art. 105 and art. 106 Pzp. in order to confirm the compliance of the offered supplies with the requirements, features or criteria specified in the description of the subject of the order or the criteria for evaluating offers or requirements related to the execution of the order, the Contracting Authority requests the Contractors to submit the following documents: • A valid marketing authorization for the medicinal product issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, as of the offer submission date, or • A valid marketing authorization for the medicinal product issued by the Council of the European Union or the European Commission, as of the offer submission date. 9.1. Pursuant to art. 107 sec. 1 of the Pzp Act. The Contractor is obliged to submit the aforementioned subject evidence together with the offer and should exercise due diligence to ensure that these documents are complete and contain all necessary information enabling the Contracting Authority to verify their correctness. 9.2. The marketing authorization for the medicinal product must be valid and current as of the offer submission date. 9.3. The composition of the preparation and packaging must be consistent with the content of the documents referred to in point 9. 9.4. In the event that the validity of the document expires, the Contractor is obliged to provide the Contracting Authority, along with the documents referred to in point 9, with an additional document declaring the timely submission of an application for extension of the marketing authorization for the medicinal product or, if obtained, a valid marketing authorization for the medicinal product. 9.5. The Contractor is obliged to inform the Contracting Authority about the transfer of rights and obligations of the entity to another entity...

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on September 24, 2026. Last refreshed 51 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About MINISTERSTWO ZDROWIA

MINISTERSTWO ZDROWIA has issued 261 procurement notices on BidsFactory, including 4 currently open and 76 awarded contracts. Activity concentrates in Health & Medical, Research & Innovation, and Education & Training. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU), Poland e-Zamówienia, and Baza Konkurencyjności. Most recent publication: November 17, 2026.

MINISTERSTWO ZDROWIA: buyer profile, tenders and awards

Frequently asked questions about this tender

How much was the contract awarded for?

POLYPHARM S.A. was awarded the contract for €5,100,000. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to POLYPHARM S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by MINISTERSTWO ZDROWIA in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories